DK0743851T3 - Lipofile bærepræparater - Google Patents

Lipofile bærepræparater

Info

Publication number
DK0743851T3
DK0743851T3 DK95909185T DK95909185T DK0743851T3 DK 0743851 T3 DK0743851 T3 DK 0743851T3 DK 95909185 T DK95909185 T DK 95909185T DK 95909185 T DK95909185 T DK 95909185T DK 0743851 T3 DK0743851 T3 DK 0743851T3
Authority
DK
Denmark
Prior art keywords
polar
pct
pharmaceutical composition
relates
polar lipid
Prior art date
Application number
DK95909185T
Other languages
English (en)
Inventor
Anders Carlsson
Bengt Hersloef
Original Assignee
Lipocore Holding Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9400368A external-priority patent/SE9400368D0/xx
Priority claimed from SE9402456A external-priority patent/SE517678C2/sv
Application filed by Lipocore Holding Ab filed Critical Lipocore Holding Ab
Application granted granted Critical
Publication of DK0743851T3 publication Critical patent/DK0743851T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/064—Water-in-oil emulsions, e.g. Water-in-silicone emulsions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A23D7/0053—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L35/00—Food or foodstuffs not provided for in groups A23L5/00 – A23L33/00; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
DK95909185T 1994-02-04 1995-02-06 Lipofile bærepræparater DK0743851T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9400368A SE9400368D0 (sv) 1994-02-04 1994-02-04 Glycolipid material
SE9402456A SE517678C2 (sv) 1994-07-12 1994-07-12 Lipofila bärarpreparat med en kontinuerlig lipidfas
PCT/SE1995/000117 WO1995020945A1 (en) 1994-02-04 1995-02-06 Lipophilic carrier preparations

Publications (1)

Publication Number Publication Date
DK0743851T3 true DK0743851T3 (da) 2001-09-03

Family

ID=26661956

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95909185T DK0743851T3 (da) 1994-02-04 1995-02-06 Lipofile bærepræparater

Country Status (19)

Country Link
US (1) US5716639A (da)
EP (1) EP0743851B1 (da)
JP (1) JP3203359B2 (da)
KR (1) KR100220546B1 (da)
CN (1) CN1091591C (da)
AT (1) ATE201980T1 (da)
AU (1) AU691250B2 (da)
CA (1) CA2182577C (da)
DE (1) DE69521300T2 (da)
DK (1) DK0743851T3 (da)
ES (1) ES2158084T3 (da)
FI (1) FI963066A (da)
HU (1) HU221432B (da)
MY (1) MY112435A (da)
NO (1) NO312495B1 (da)
NZ (1) NZ279954A (da)
PL (1) PL178394B1 (da)
TW (1) TW482685B (da)
WO (1) WO1995020945A1 (da)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9403855D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
CZ292346B6 (cs) * 1996-05-10 2003-09-17 Yamanouchi Europe B. V. Prášek reverzních vezikul, způsob jeho výroby a použití a kompozice na jeho bázi
EP0918465B1 (en) * 1996-05-10 2005-01-12 Unilever N.V. Liquid fatty component containing composition
GR1002706B (el) * 1996-05-22 1997-05-26 Μικρογαλακτωματα λεκιθινης περιεχοντα πρωτεολυτικα ενζυμα α-χυμοθρυψινης η θρυψινη και μεθοδος μονιμης ενζυμικης αποτριχωσης.
DE19645657A1 (de) * 1996-11-06 1998-05-28 Rhone Poulenc Rorer Gmbh Phospholipidische Zusammensetzung, Verfahren zur Herstellung einer derartigen Zusammensetzung und Verwendung derselben
SE9702630D0 (sv) * 1997-07-07 1997-07-07 Scotia Lipidteknik Ab Satiety product
US6017545A (en) * 1998-02-10 2000-01-25 Modi; Pankaj Mixed micellar delivery system and method of preparation
US7070799B1 (en) * 1998-02-10 2006-07-04 Generex Pharmaceuticals, Inc. Method for administering insulin to the buccal region
US6221378B1 (en) 1998-02-10 2001-04-24 Generex Pharmaceuticals Incorporated Mixed micellar delivery system and method of preparation
DE19819273A1 (de) * 1998-04-30 1999-11-11 Pharmatec International S Giul Pharmazeutische Ciclosporin-Formulierung mit verbesserten biopharmazeutischen Eigenschaften, erhöhter physikalischer Qualität und Stabilität sowie Verfahren zur Herstellung
SE9804192D0 (sv) * 1998-12-03 1998-12-03 Scotia Lipidteknik Ab New formulation
EP1043016B1 (en) * 1999-03-30 2014-08-20 Sodic Sa A plant extract based on glycerides,phospholipids and phytosphingolipids, a method for the preparation of this extract and a cosmetic composition containing the same
US6916488B1 (en) * 1999-11-05 2005-07-12 Biocure, Inc. Amphiphilic polymeric vesicles
SE0000730D0 (sv) * 2000-03-06 2000-03-06 Scotia Holdings Plc Lipid carrier
DE10019171A1 (de) * 2000-04-07 2001-10-18 Schering Ag Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe
EP1151745A1 (fr) * 2000-05-05 2001-11-07 L'oreal Composition sous forme d'émulsion eau-dans-huile et ses utilisations cosmétiques
WO2003035112A1 (fr) * 2001-10-22 2003-05-01 Jiro Kanie Nutriant enteral et procede de production de celui-ci
US20030113366A1 (en) * 2001-12-14 2003-06-19 Macgregor Alexander Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
SE0201922D0 (sv) * 2002-06-20 2002-06-20 Ltp Lipid Technologies Provide Koagulationshindrande komposition (Anticoagulant Composition)
SE0300207D0 (sv) 2003-01-29 2003-01-29 Karolinska Innovations Ab New use and composition
US7658964B2 (en) * 2003-05-09 2010-02-09 Freedom Health, Llc Dietary supplement and method for increasing the colostrum immunoglobulin levels in equine mares
US7988989B2 (en) * 2003-05-09 2011-08-02 Freedom Health, Llc Nutritional product for enhancing growth and/or strengthening the immune system of equine foals
US20050058671A1 (en) * 2003-05-09 2005-03-17 Bedding Peter M.J. Dietary supplement and method for treating digestive system-related disorders
US7824706B2 (en) 2003-05-09 2010-11-02 Freedom Health, Llc Dietary supplement and method for the treatment of digestive tract ulcers in equines
DE10336841A1 (de) * 2003-08-11 2005-03-17 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Kosmetische Zusammensetzung zur Unterstützung des Sauerstofftransports in die Haut
PT1530965E (pt) 2003-11-11 2006-05-31 Udo Mattern Sistema de administracao de libertacao controlada de hormonas sexuais para aplicacao nasal
US8784869B2 (en) 2003-11-11 2014-07-22 Mattern Pharma Ag Controlled release delivery system for nasal applications and methods of treatment
CA2537029C (en) * 2003-11-26 2013-03-12 Likan Liang Micellar systems useful for delivery of lipophilic or hydrophobic compounds
WO2006067402A2 (en) 2004-12-22 2006-06-29 Lipopeptide Ab Agents inibiting the cathelin-like protein cap18/ll-37
EA012448B1 (ru) * 2005-03-04 2009-10-30 ДСМ АйПи АССЕТС Б.В. Пищевая липидная композиция в форме частиц
DE102005023636A1 (de) * 2005-05-19 2006-11-23 Beiersdorf Ag Wirkstoffkombinationen aus Glucosylglyceriden und Kreatin und / oder Kreatinin
DE102005023638A1 (de) * 2005-05-19 2006-11-23 Beiersdorf Ag Kosmetische Zubereitungen mit einem Gehalt an Glucosylglyceriden und einem oder mehreren Acrylamidomethylpropylsulfonsäure-Polymeren
DE102005023640A1 (de) * 2005-05-19 2006-11-23 Beiersdorf Ag Wirkstoffkombinationen aus Glucosylglyceriden und einem oder mehreren partiell neutralisierten Ester von Monoglyceriden und / oder Diglyceriden gesättigter Fettsäuren mit Zitronensäure
EA012422B1 (ru) * 2005-09-16 2009-10-30 ДСМ АйПи АССЕТС Б.В. Фармацевтическая липидная композиция в виде частиц
ATE496617T1 (de) 2006-10-04 2011-02-15 M & P Patent Ag Abgabesystem mit gesteuerter freisetzung zur nasalen anwendung von neurotransmittern
WO2009019891A1 (ja) * 2007-08-09 2009-02-12 Kao Corporation 逆ベシクル組成物
US20090137497A1 (en) * 2007-11-23 2009-05-28 Beiersdorf Ag Active ingredient combinations of glucosyl glycerides and creatine and/or creatinine
US20090285869A1 (en) * 2008-05-14 2009-11-19 Humco Holding Group, Inc. Salt stable lecithin organogel composition
JP2010104946A (ja) * 2008-10-31 2010-05-13 Riso Kagaku Corp 逆ベシクルを用いて形成された油中水（ｗ／ｏ）型エマルション
CN101787059B (zh) * 2009-05-12 2014-10-15 沈阳药科大学 双半乳糖基二酰甘油酯的制备方法及其应用
PT2550020E (pt) * 2010-03-24 2015-10-20 Medesis Pharma Microemulsão de micelas reversas compreendendo iões metálicos e sua utilização
EP2575768B1 (en) * 2010-05-24 2017-12-13 Swedish Oat Fiber AB Aqueous dispersion comprising galactolipids and method for production thereof
EP2389816A1 (en) 2010-05-25 2011-11-30 Nestec S.A. Synergistic antioxidant composition
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
AR086400A1 (es) 2011-05-13 2013-12-11 Trimel Pharmaceuticals Corp Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
JP6239822B2 (ja) * 2012-12-27 2017-11-29 ポーラ化成工業株式会社 逆ベシクル組成物
WO2014103742A1 (ja) * 2012-12-25 2014-07-03 ポーラ化成工業株式会社 逆ベシクル組成物及びその製造方法
JP6242581B2 (ja) * 2013-04-01 2017-12-06 ポーラ化成工業株式会社 逆ベシクル組成物の製造方法
JP6242582B2 (ja) * 2013-04-01 2017-12-06 ポーラ化成工業株式会社 逆ベシクル組成物の製造方法
JP6334151B2 (ja) * 2012-12-25 2018-05-30 ポーラ化成工業株式会社 逆ベシクル組成物
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
KR20160002929A (ko) * 2013-04-16 2016-01-08 다우 글로벌 테크놀로지스 엘엘씨 저지방 라미네이트된 도우 및 패스트리
WO2020237383A1 (en) * 2019-05-31 2020-12-03 Groupe Santé Devonian Inc. Thylakoids as delivery system for cannabinoïds and other molecules and formulations thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0009842B1 (en) * 1978-10-02 1982-11-10 THE PROCTER & GAMBLE COMPANY Liposomes for drug delivery and composition containing a liposome drug system
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
CA1320130C (en) * 1986-06-12 1993-07-13 Alan L. Weiner Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
US5234767A (en) * 1987-03-13 1993-08-10 Micro-Pak, Inc. Hybrid paucilamellar lipid vesicles
SE9003100D0 (sv) * 1990-09-28 1990-09-28 Kabivitrum Ab Lipid formulation system
JP2774429B2 (ja) * 1992-03-17 1998-07-09 株式会社ディ・ディ・エス研究所 糖骨格を有する分枝鎖型誘導体

Also Published As

Publication number Publication date
AU691250B2 (en) 1998-05-14
WO1995020945A1 (en) 1995-08-10
EP0743851B1 (en) 2001-06-13
NO312495B1 (no) 2002-05-21
NO963242D0 (no) 1996-08-02
FI963066A0 (fi) 1996-08-02
MY112435A (en) 2001-06-30
CA2182577A1 (en) 1995-08-10
ATE201980T1 (de) 2001-06-15
DE69521300D1 (de) 2001-07-19
JP3203359B2 (ja) 2001-08-27
ES2158084T3 (es) 2001-09-01
NZ279954A (en) 1998-02-26
TW482685B (en) 2002-04-11
CN1140405A (zh) 1997-01-15
PL315780A1 (en) 1996-12-09
CN1091591C (zh) 2002-10-02
HUT75470A (en) 1997-05-28
US5716639A (en) 1998-02-10
EP0743851A1 (en) 1996-11-27
NO963242L (no) 1996-08-02
HU9602142D0 (en) 1996-09-30
CA2182577C (en) 2002-08-20
FI963066A (fi) 1996-09-30
AU1723595A (en) 1995-08-21
JPH09508415A (ja) 1997-08-26
PL178394B1 (pl) 2000-04-28
KR100220546B1 (ko) 1999-09-15
HU221432B (en) 2002-10-28
DE69521300T2 (de) 2002-05-02

Similar Documents

Publication Publication Date Title
DK0743851T3 (da) Lipofile bærepræparater
TW288979B (da)
MY113341A (en) Bilayer preparations
FR2597335B1 (fr) Composition cosmetique permettant de lutter contre l'aspect gras des cheveux, et son utilisation.
ATE221369T1 (de) Emulsion enthaltend eine gelierte wässerige aüssere phase, eine nichtwässerige zwischenphase und eine wässerige innere phase
ATE156703T1 (de) Solubilisierungsmittel
DE69114922T2 (de) Polysulfidverbindungen und Lipidperoxidierungsinhibitore, die diese Polysulfidverbindungen als aktive Zutaten enthalten.
SE9402454L (sv) Olja-i-vatten-emulsioner
SE9402456L (sv) Lipofila bärarpreparat
ATE206036T1 (de) Kombination eines zinksalicylats und eines serenoa repens-extrakts zur behandlung der seborrhö und diese enthaltende kosmetische hautpflegemittel